Literature DB >> 15599473

Guidelines for chemotherapy of tuberculosis in Taiwan.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15599473

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN： 1684-1182            Impact factor:   4.399


× No keyword cloud information.
  4 in total

1.  Impact of the E540V amino acid substitution in GyrB of Mycobacterium tuberculosis on quinolone resistance.

Authors:  Hyun Kim; Chie Nakajima; Kazumasa Yokoyama; Zeaur Rahim; Youn Uck Kim; Hiroki Oguri; Yasuhiko Suzuki
Journal:  Antimicrob Agents Chemother       Date:  2011-06-06       Impact factor: 5.191

2.  Effective interventions and decline of antituberculosis drug resistance in Eastern Taiwan, 2004-2008.

Authors:  Yi-Ting Chen; Jen-Jyh Lee; Chen-Yuan Chiang; Gee-Gow Yang; Yeong-Chu Tsai; Yeong-Sheng Lee; Chih-Bin Lin
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

3.  Comparison of the safety and efficacy of a fixed-dose combination regimen and separate formulations for pulmonary tuberculosis treatment.

Authors:  Jiun-Ting Wu; Chien-Tung Chiu; Yu-Feng Wei; Yung-Fa Lai
Journal:  Clinics (Sao Paulo)       Date:  2015-06-01       Impact factor: 2.365

4.  Clinical characteristics and treatment outcomes of patients with low- and high-concentration isoniazid-monoresistant tuberculosis.

Authors:  Tsai-Yu Wang; Shu-Min Lin; Shian-Sen Shie; Pai-Chien Chou; Chien-Da Huang; Fu-Tsai Chung; Chih-His Kuo; Po-Jui Chang; Han-Pin Kuo
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.